Search results

Page results

• Organisations offering financial advice to people affected by cancer and blood conditions

  Organisations and services offering financial advice to people affected by cancer and blood conditions, and their familes and carers.

• UCLH announces start of CAR T cell therapy clinical trial for lupus patients

  Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.

• The Female Genital Cutting / Mutilation (FGC/M) Children and Young People’s Clinic

  The UCLH children’s FGC/M clinic provides specialist care for children and adolescents who have undergone or are at risk of FGC/M.

• Teenage and Young Adult Ambulatory Care Service

  This page provides an overview of our Teenage and Young Adult (TYA) Ambulatory Care Service available to patients aged 12 to 24 years.

• Self-administration of bortezomib

  This step-by-step guide explains how you can give yourself an injection of bortezomib at home.

• FACETS: A Fatigue Management Group

  This page explains what FACETS is and how it can help you.

• Complex Facial Clinic - Botulinum toxin injections as part of the clinic treatment

  This page explains the use of botulinum toxin in the management of facial weakness and synkinesis as part of treatment process in the complex facial clinic.

• Functional Electrical Stimulation (FES) Clinic

  Patient information leaflet for Functional Electrical Stimulation (FES) Clinic

• GReaT - Getting Ready for Transition to secondary school

  The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.

• First patient takes part in new Phase 1 clinical trial for patients with recurrent glioblastoma

  To mark International Brain Tumour Awareness Week, UCLH and The National Brain Appeal are announcing a new clinical trial for patients with recurrent glioblastoma brain cancer.